Advertisement
Screener

Deciphera Pharmaceuticals, Inc. Patents: Expired

Deciphera Pharmaceuticals, Inc. Expired Patents

2 granted patents the USPTO lists as expired; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2014-03-14: Application 14214127; Invention PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES; Applicant Deciphera Pharmaceuticals, LLC; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
  • 2013-03-05: Application 13785575; Invention RAF INHIBITOR COMPOUNDS; Applicant Deciphera Pharmaceuticals, LLC; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2014-03-1414214127PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIESDeciphera Pharmaceuticals, LLCPatent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622015-04-219012635US20140343103A1
Daniel L. Flynn
Michael D. Kaufman
United States
United States
CHANDRAKUMAR, NIZAL S
2013-03-0513785575RAF INHIBITOR COMPOUNDSDeciphera Pharmaceuticals, LLC
Eli Lilly and Company
Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622014-06-038741911US20130252977A1
Matthew Carl Allgeier
Daniel L. Flynn
Michael D. Kaufman
Phenil J. Patel
Craig D. Wolfangel
United States
United States
United States
United States
United States
MURRAY, JEFFREY H